Tags

MediSix Therapeutics

IASO Biotechnology acquires Singapore cell therapy firm MediSix Therapeutics

IASO Biotechnology acquires Singapore cell therapy firm MediSix Therapeutics

August 14, 2026 | 15:54
Chinese biopharmaceutical developer IASO Biotechnology completed the full acquisition of Singapore-based immune cell engineering firm MediSix Therapeutics on 13 August 2026 to expand cellular therapy capabilities.

Latest News

DoGo Power receives EUPD Research European top innovation award 2026

DoGo Power receives EUPD Research European top innovation award 2026

Dimora Medical enters Amazon top three wound dressing ranking list

Dimora Medical enters Amazon top three wound dressing ranking list

Pudu Robotics secures top global rank in commercial cleaning shipments

Pudu Robotics secures top global rank in commercial cleaning shipments

IBM partners with OpenAI to accelerate enterprise artificial intelligence deployment

IBM partners with OpenAI to accelerate enterprise artificial intelligence deployment

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020